2/5
09:07 am
acrv
Acrivon Therapeutics gets FDA breakthrough device designation for its oncosignature assay for endometrial cancer [Seeking Alpha]
High
Report
Acrivon Therapeutics gets FDA breakthrough device designation for its oncosignature assay for endometrial cancer [Seeking Alpha]
2/5
08:00 am
acrv
Acrivon Therapeutics Announces FDA has Granted Breakthrough Device Designation for ACR-368 OncoSignature Assay for Endometrial Cancer
High
Report
Acrivon Therapeutics Announces FDA has Granted Breakthrough Device Designation for ACR-368 OncoSignature Assay for Endometrial Cancer
1/31
10:27 am
acrv
Acrivon Therapeutics, Inc. (NASDAQ: ACRV) is now covered by analysts at Cantor Fitzgerald. They set an "overweight" rating on the stock.
Low
Report
Acrivon Therapeutics, Inc. (NASDAQ: ACRV) is now covered by analysts at Cantor Fitzgerald. They set an "overweight" rating on the stock.
1/31
08:32 am
acrv
Acrivon Therapeutics, Inc. (NASDAQ: ACRV) is now covered by analysts at KeyCorp. They set an "overweight" rating on the stock.
Medium
Report
Acrivon Therapeutics, Inc. (NASDAQ: ACRV) is now covered by analysts at KeyCorp. They set an "overweight" rating on the stock.
11/13/2024
07:00 am
ACRV
acrivon therapeutics, inc.
MISS
Report
-6.4%
acrivon therapeutics, inc.
8/13/2024
08:00 am
ACRV
acrivon therapeutics, inc.
BEAT
Report
-4.5%
acrivon therapeutics, inc.
5/14/2024
07:31 am
ACRV
acrivon therapeutics, inc.
BEAT
Report
-1.4%
acrivon therapeutics, inc.
3/14
04:45 pm
acrv
Form 8-K Acrivon Therapeutics, For: Mar 11
Neutral
Report
Form 8-K Acrivon Therapeutics, For: Mar 11
3/4
05:37 pm
acrv
Form 4 Acrivon Therapeutics, For: Mar 01 Filed by: Peterson Katharine
Medium
Report
Form 4 Acrivon Therapeutics, For: Mar 01 Filed by: Peterson Katharine
3/4
05:32 pm
acrv
Form 4 Acrivon Therapeutics, For: Mar 01 Filed by: Miller Mary
Medium
Report
Form 4 Acrivon Therapeutics, For: Mar 01 Filed by: Miller Mary
3/4
05:29 pm
acrv
Form 4 Acrivon Therapeutics, For: Mar 01 Filed by: Holm-Jorgensen Rasmus
Medium
Report
Form 4 Acrivon Therapeutics, For: Mar 01 Filed by: Holm-Jorgensen Rasmus
3/4
05:24 pm
acrv
Form 4 Acrivon Therapeutics, For: Mar 01 Filed by: Gamelin Erick
Medium
Report
Form 4 Acrivon Therapeutics, For: Mar 01 Filed by: Gamelin Erick
3/4
05:22 pm
acrv
Form 4 Acrivon Therapeutics, For: Mar 01 Filed by: Devroe Eric
Medium
Report
Form 4 Acrivon Therapeutics, For: Mar 01 Filed by: Devroe Eric
3/4
05:14 pm
acrv
Form 4 Acrivon Therapeutics, For: Mar 01 Filed by: Cuillerot Jean-Marie
Medium
Report
Form 4 Acrivon Therapeutics, For: Mar 01 Filed by: Cuillerot Jean-Marie
3/4
05:12 pm
acrv
Form 4 Acrivon Therapeutics, For: Mar 01 Filed by: Blume-Jensen Peter
Medium
Report
Form 4 Acrivon Therapeutics, For: Mar 01 Filed by: Blume-Jensen Peter
News Stats
All News
News Wires
Media Monitoring
SEC Edgar Filings
Upgrades
Downgrades
Initiated
Reiterated
Last Earnings
Last Earnings EPS
Next Earnings
Order Stats
Sub-Penny
Odd lot
Avg. bid-ask spread
Avg. bid-ask size
Shares at ask/bid
Off exchange
Main News & Impact Reports
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below:
Register